Marked atherosclerosis in a patient with familiar lecithin : cholesterol acyltransferase deficiency associated with end-stage renal disease and diabetes mellitus

Citation
S. Homma et al., Marked atherosclerosis in a patient with familiar lecithin : cholesterol acyltransferase deficiency associated with end-stage renal disease and diabetes mellitus, AM J NEPHR, 21(5), 2001, pp. 415-419
Citations number
20
Categorie Soggetti
Urology & Nephrology
Journal title
AMERICAN JOURNAL OF NEPHROLOGY
ISSN journal
02508095 → ACNP
Volume
21
Issue
5
Year of publication
2001
Pages
415 - 419
Database
ISI
SICI code
0250-8095(200109/10)21:5<415:MAIAPW>2.0.ZU;2-G
Abstract
Familial lecithin:cholesterol acyltransferase (LCAT) deficiency is a rare g enetic disorder of the lipid metabolism caused by the absence of LCAT activ ity in plasma. It is not generally accompanied by atherosclerosis in spite of low high-density lipoprotein cholesterol levels nor by diabetes mellitus . However, reports of long-term followup or autopsy findings are rare, and the true incidence of atherosclerosis in LCAT deficiency is not clear. We r eport on the long-term observation of a patient with familial LCAT deficien cy who developed renal failure, diabetes mellitus, and marked atheroscleros is. The patient died of sepsis from foot ulcers 7 years after starting hemo dialysis and 13 years after the diagnosis. Marked atherosclerosis character ized by medial calcification in small arteries was observed at autopsy. The genesis of the atherosclerosis seemed to be on the basis of a combination of factors. Copyright (C) 2001 S. Karger AG, Basel.